Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT04758611Not ApplicableActive Not Recruiting

The ETCHES I Study (Endovascular Treatment of Communicating Hydrocephalus With an Endovascular Shunt)

Role: collaborator

NCT05250505Not ApplicableActive Not Recruiting

Pilot Study of the CereVasc® eShunt® System in Normal Pressure Hydrocephalus

Role: collaborator

NCT05574777Not ApplicableActive Not Recruiting

Endoscopic Gastric Mucosal Ablation (GMA) of Class III Obesity

Role: collaborator

All 3 trials loaded